首都信息(01075.HK)接獲數份法院傳票和應訴通知書
格隆匯10月25日丨首都信息(01075.HK)公告,公司近日接獲數份分別由福建省廈門市思明區人民法院及福建省廈門市湖裏區人民法院的傳票和應訴通知書,廈門融通信息技術有限責任公司的原數名自然人股東以個人身份向人民法院提出起訴狀,請求人民法院判令(一)繼續覆行公司與融通公司原股東於2014年7月21日所簽署的《股權轉讓協定》;(二)公司向該等人士支付股權轉讓款合共人民幣約2220.1,5萬元;及(三)逾期付款期間的資金佔用利息,按中國人民銀行同期同類貸款利率分別自2017年9月1日(前述股權轉讓款的50%)、2018年9月1日(前述股權轉讓款的50%)計算至實際支付日為止及案件受理費。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.